Thursday, September 04, 2014

CBSA Launches New “BioTalks” at BioWest 2014 in Denver; People Talking About Big, Bold Ideas

Colorado BioScience Association (CBSA) is launching new “BioTalks” at BioWest this year. These are eight fast-paced presentations about the big and bold ideas in the Bioscience Industry. The announcement is made by CBSA President and CEO April Giles, who says, “This year we’ve added energy and excitement to our lineup with the new BioTalk segments during regular programming and the new C-Level Unplugged interviews on center stage in the Expo Hall. Further, we’re very excited about the number of high caliber keynote speakers at BioWest 2014, including FDA Commissioner Dr. Margaret Hamburg, Russell Slifer the newly appointed Director of the Rocky Mountain Region’s Satellite U.S. Patent and Trade Mark Office, CEO presentations, and the wide variety of products and services on display in the Expo Hall.”

The 2014 BioWest Conference and Expo, is September 10, at the Marriott City Center, 1701 California Street, Denver.

BioTalks are scheduled at both 10:45 a.m. and 3:00 p.m.

Morning Session:

Trends in Healthcare: Investments & Exits Jonathan Norris, Managing Director, Silicon Valley Bank 

Ethics in Clinical Trials David Gary, RN, MS, Director, Human Research Protection Program, Catholic Health Initiatives/CHI Institute for Research & Innovation (CIRI)

Harnessing the Power of Real World Data to Identify What Works for Whom in Healthcare Iya Khalil, Ph.D., Executive Vice President and Co-Founder, GNS Healthcare

Afternoon Session:

Cultivating the Innovation Economy Robert Atkinson, President, Information Technology and Innovation Foundation

The Truth behind Superbugs Rhea May, Ph.D., Research Scientist, Sharklet Technologies

Leveraging Outsourcing to Bridge the Valley of Death: Advantages & Pitfalls Larry Blankenship, Executive Director, Evergreen Research

Industry Cross Collaboration Mark Sirangelo, Chief Innovation Officer, State of Colorado; Corporate VP of Space Systems, Sierra Nevada Corp 

Beer Fermentation Science: Yeast Strains & Sensory Perception Lindsay Guerdrum, Sensory Specialist, New Belgium Brewing

Also new this year: C-Level Unplugged 

In addition to BioTalk presentations, BioWest 2014 is also debuting two sessions of “C-Level Unplugged: Conversations with top level leadership.” The morning session, 9:20 – 9:35, will feature a fast-paced interview on the Exhibit Hall stage with Larry Gold, Chairman of the Board, SomaLogic. The afternoon session, 1:15 – 1:30 pm, features Shahriar (Shar) Matin, Chief Operating Officer of Spectranetics. Jim Wilson, partner, EY, will conduct the interview for both sessions during the conference.

About BioWest 2014 | September 10, 2014 | #BioWest2014 

The BioWest Conference is a one day event attended by more than 300 industry leaders, government representatives, executives, researchers, investors and entrepreneurs. The conference features speakers Margaret A. Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration (her ‘Update on the FDA’ keynote will occur at 4:45 pm) sponsored by Dohmen and keynote panelists; Jandel Allen-Davis, M.D., Vice President, Government and External Relations, Kaiser Permanente Colorado; James Hill, Ph.D. is Professor of Pediatrics and Medicine at the University of Colorado School of Medicine; Len Tacconi, President, HMR Weight Management Services Corp., a subsidiary of Merck & Co. Inc.; sponsored by the Fitzsimons Redevelopment Authority and Russell Slifer, Director, United States Patent and Trademark, Rocky Mountain Regional Office sponsored by Sheridan Ross PC. The full schedule of the day’s events is found at:

Registration is now open at Rates for members start at $325 and $375 for non-members and passes for the expo hall and reception only are $125 for members and $150 for non-members. Group rates are available for companies and organizations. BioWest 2014 also includes an Exhibit Hall with over 40 exhibitors showcase new technologies, products and services to attendees. Conference Sponsors include: AdvaMed, Amgen, BIO, BioFrontiers Institute, DePuy Synthes, DaVita Clinical Research, Dorsey & Whitney LLP, Dohmen Life Science Services, EY, Evergreen Research, Fitzsimons Redevelopment Authority, Fisher Scientific, Metro Denver EDC, The Mead Consulting Group, Quintiles, SomaLogic, Sheridan Ross PC, Square 1 Bank, Silicon Valley Bank and TerumoBCT.

Link to the PitchEngine social media release

No comments:

Post a Comment